Skip to main content

Table 2 Rush mOIT dose escalation schedule

From: Phase 1 results of safety and tolerability in a rush oral immunotherapy protocol to multiple foods using Omalizumab

Dose of protein (mg)

Interval in weeks

% of increase from previous

2350 mg

2

88%

4000 mg

2

70%

5800 mg

2

45%

7600 mg

2

50%

9400 mg

2

30%

11200 mg

2

20%

14000 mg

2

25%

17500 mg

2

25%

20000 mg

2

14%

Back to article page

Allergy, Asthma & Clinical Immunology

ISSN: 1710-1492

Contact us